#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepatoblastoma Glomerulonephritis membranous Duchenne muscular dystrophy Post transplant lymphoproliferative disorder Bladder cancer Uterine leiomyosarcoma Follicular lymphoma stage III Cataract Choroidal dystrophy VEXAS syndrome Prostate cancer Malignant fibrous histiocytoma Ventricular tachycardia Crohn's disease Thromboangiitis obliterans More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Trials in Disease Alagille syndrome – Diagnostics Hepatic angiosarcoma – Diagnostics Osteosarcoma – Treatment Piriformis syndrome – Trials in Disease Focal segmental glomerulosclerosis – Diagnostics Hereditary optic atrophy – Life with Disease Prader-Willi syndrome – Treatment Alagille syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ubiquinol Filgrastim Murcidencel Pentosan Polysulfate Sodium Micafungin Opelconazole GSKVX000000044501 Depemokimab Topiramate Risperidone Tigecycline Levosimendan LYSERGIDE Medi0618 Dorocubicel GSK4418959A Mps-102 Meropenem Anhydrous Treg02 Nilutamide More therapies…

    Learn about Your Condition

    Metachromatic leukodystrophy Anaemia Eosinophilic gastritis Proteinuria Bone metabolism disorder Thyroid mass Round cell liposarcoma Aplastic anaemia Elderly Bronchopulmonary aspergillosis Frontotemporal dementia Neuroblastoma Leukoencephalopathy Ventricular tachycardia Breast cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effectiveness of Apixaban for Pain Relief in Patients with Venous Malformations

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Arteriovenous malformation
    Investigated Drugs:
    • Apixaban
    Norway

  • Study on the Safety and Efficacy of Cevostamab with Lenalidomide or Iberdomide for Patients with High-Risk or Relapsed Multiple Myeloma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Cevostamab
    • Iberdomide
    • Lenalidomide
    France Germany Poland Spain

  • Study on Ivermectin for Treating Strongyloidiasis in Adults with Normal Immune Function

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Ivermectin
    Spain

  • Study on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Ezetimibe
    • Obicetrapib
    Czechia Hungary Italy The Netherlands Poland Spain

  • Study Comparing ANV419 and High Dose IL2 in Adoptive Cell Therapy for Patients with Melanoma, Non-Small Cell Lung Cancer, and Cervical Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Autologous Tumour-Infiltrating Lymphocytes
    • Fusion Protein Of Il-2 And Humanised Igg1 Monoclonal Antibody Against Il-2
    • Anv600
    Denmark The Netherlands Spain

  • Study of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Ibrutinib
    Italy
Previous Page
1 … 318 319 320 321 322 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!